Bcl-xL expression and regulation in the progression, recurrence, and cisplatin resistance of oral cancer.

Life Sciences
Manzar Alam, Rajakishore Mishra

Abstract

Bcl-xL is an anti-apoptotic molecule, but its role in the progression and recurrent/ drug-resistant oral squamous cell carcinoma (OSCC) is poorly understood. A total of one hundred twenty-five human OSCC tissue specimens including twenty-nine adjacent normals (AN), sixty-nine primary tumors (PT), twenty-seven recurrent chemoradiation resistance (RCRT) samples, and oral tongue SCC derived cisplatin-resistant (CisR SCC-4/-9) cells were used, for this study. Protein/mRNA expression levels of Bcl-xL and its regulation by ERK1/2, Stat-3, p53, NFκB, AP-1 (components: c-Jun, c-Fos, and Fra-2) molecules, and cell viability were measured by immunohistochemistry, Western blot, RT-PCR, and MTT analysis. Further, the individual and synergistic effects of Fra-2 (siRNA) and nimbolide were tested in CisR SCC-4/-9 cells. Progressive increase of Bcl-xL expression and its transcriptional-deregulation was observed with OSCC progression and resistance. Among all the possible upstream regulators of Bcl-xL, such as ERK1/2, Stat-3, p53, AP-1, and NFκB, the TF AP-1 (r = 0.644, p = 0.0001) showed maximum association with Bcl-xL mRNA expression. Though differential expression of AP-1 components were detected in OSCC specimens, with more striking positiv...Continue Reading

References

Jun 15, 1997·The Journal of Clinical Investigation·Y FujioT Kishimoto
Aug 24, 1999·Cell·J F BrombergJ E Darnell
Apr 13, 2000·Proceedings of the National Academy of Sciences of the United States of America·J R GrandisJ D Kim
Mar 10, 2001·International Journal of Cancer. Journal International Du Cancer·D M AebersoldV Djonov
Dec 12, 2003·Nature Reviews. Cancer·Robert Eferl, Erwin F Wagner
Jan 22, 2004·International Journal of Cancer. Journal International Du Cancer·Remilio A L SchoopMathieu H M Noteborn
Apr 2, 2004·Pharmacology & Therapeutics·Jennifer Rubin Grandis, John C Sok
Jul 19, 2005·Cancer Cell·Suzanne Cory, Jerry M Adams
Dec 22, 2007·Nature Reviews. Molecular Cell Biology·Richard J Youle, Andreas Strasser
Oct 11, 2008·Cell Death and Differentiation·K Balmanno, S J Cook
Feb 18, 2010·Molecular Cell·Jerry E ChipukDouglas R Green
May 29, 2010·The Journal of Biological Chemistry·Ahmad SalamehSalvatore Oliviero
Mar 29, 2011·Biochemical and Biophysical Research Communications·Sarah ParkYoung-Hyuck Im
Aug 20, 2011·Expert Opinion on Investigational Drugs·Bridget A QuinnPaul B Fisher
Jul 31, 2012·Oral Oncology·Guilherme Rabinowits, Robert I Haddad
Nov 21, 2016·Oral Oncology·Prajna Paramita NaikSujit Kumar Bhutia
May 27, 2017·The FEBS Journal·Simon J CookMatthew J Sale
Dec 12, 2018·Oral Oncology·Anil K D'CruzHarsh Dhar
Jan 13, 2019·Journal of Cancer Research and Clinical Oncology·Keisuke InoueTamotsu Takeuchi
Mar 19, 2020·Cells·Maxime JullienCyrille Touzeau

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.